Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Steve168 who wrote (17486)	7/31/2003 2:21:11 AM
From: Spekulatius	Respond to of 78523

I am vaguely familiar with PCYC. The stock obviously has some issues otherwise it would not be trading where it does right now. their lead drug Xcytrin had questionable trial results about 1-2 years ago. i also remember that management has not been forthcoming about those results which creates a credibility issue. I have not followed them for quite a while though, they got a mental "Do not touch tag" attached for me as well as for many other seasoned biotech investors.